Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Protein Design Labs news

PDLI received a scheduled $45 million equity investment from Corange Ltd. as part of the companies' October 1993 partnership.

Corange purchased 1.23 million shares at $36.50 a share, bringing its holdings to

Read the full 325 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE